AOLS (Aeolus Pharmaceuticals) Total Assets: $0.79 Mil (As of Jun. 2017)


What is Aeolus Pharmaceuticals Total Assets?

Aeolus Pharmaceuticals AOLS Total Assets is $0.79 Mil as of Jun. 2017.

Aeolus Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2017 was $0.79 Mil.

Total Assets is connected with ROA %. Aeolus Pharmaceuticals's annualized ROA % for the quarter that ended in Jun. 2017 was -296.68%. Total Assets is also linked to Revenue through Asset Turnover. Aeolus Pharmaceuticals's Asset Turnover for the quarter that ended in Jun. 2017 was 0.01.

Aeolus Pharmaceuticals  (OTCPK:AOLS) Total Assets Explanation

Total Assets is connected with ROA %.

Aeolus Pharmaceuticals's annualized ROA % for the quarter that ended in Jun. 2017 is

ROA %=Net Income (Q: Jun. 2017 )/( (Total Assets (Q: Mar. 2017 )+Total Assets (Q: Jun. 2017 ))/ count )
=-3.796/( (1.765+0.794)/ 2 )
=-3.796/1.2795
=-296.68 %

Note: The Net Income data used here is four times the quarterly (Jun. 2017) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aeolus Pharmaceuticals's Asset Turnover for the quarter that ended in Jun. 2017 is

Asset Turnover
=Revenue (Q: Jun. 2017 )/( (Total Assets (Q: Mar. 2017 )+Total Assets (Q: Jun. 2017 ))/ count )
=0.013/( (1.765+0.794)/ 2 )
=0.013/1.2795
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aeolus Pharmaceuticals Total Assets Related Terms

Aeolus Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Aeolus Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aeolus Pharmaceuticals Total Assets Chart

Aeolus Pharmaceuticals Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.26 1.97 3.58 1.78 4.17

Aeolus Pharmaceuticals Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.87 4.17 2.65 1.77 0.79

Aeolus Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aeolus Pharmaceuticals's Total Assets for the fiscal year that ended in Sep. 2016 is calculated as

Total Assets=Total Equity (A: Sep. 2016 )+Total Liabilities (A: Sep. 2016 )
=3.195+0.972
=4.17

Aeolus Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2017 is calculated as

Total Assets=Total Equity (Q: Jun. 2017 )+Total Liabilities (Q: Jun. 2017 )
=0.207+0.587
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.79 Mil mean?
Aeolus Pharmaceuticals (AOLS) has a Total Assets of $0.79 Mil as of Jun. 2017. The total amount of assets as recorded on a company's balance sheet. View historical data on Aeolus Pharmaceuticals and its competitors.
Is Aeolus Pharmaceuticals' Total Assets too high?
Aeolus Pharmaceuticals' current Total Assets is $0.79 Mil.
How does Aeolus Pharmaceuticals' Total Assets compare to RDGL and PCYN?
Aeolus Pharmaceuticals' Total Assets of $0.79 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Aeolus Pharmaceuticals and its competitors. Aeolus Pharmaceuticals's current Total Assets is $0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aeolus Pharmaceuticals stock overvalued right now?
Aeolus Pharmaceuticals (AOLS) has a current Total Assets of $0.79 Mil. The current Total Assets is $0.79 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Aeolus Pharmaceuticals (AOLS), the current Total Assets is $0.79 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aeolus Pharmaceuticals Business Description

Address 26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.